[{"orgOrder":0,"company":"Pharosgen","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"SOUTH KOREA","productType":"Undisclosed","year":"2025","type":"Inapplicable","leadProduct":"MPD-1","moa":"Undisclosed","graph1":"Oncology","graph2":"Phase I","graph3":"Pharosgen","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Pharosgen \/ Inapplicable","highestDevelopmentStatusID":"6","companyTruncated":"Pharosgen \/ Inapplicable"}]
Find Clinical Drug Pipeline Developments & Deals by Pharosgen
Filters
×
FILTER:
Company Name
Year
DEALS // DEV.
Country
Sponsor
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target